A detailed history of Bessemer Group Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Bessemer Group Inc holds 8,961 shares of UTHR stock, worth $3.38 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,961
Previous 52 17132.69%
Holding current value
$3.38 Million
Previous $17,000 18782.35%
% of portfolio
0.01%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$311.04 - $363.55 $2.77 Million - $3.24 Million
8,909 Added 17132.69%
8,961 $3.21 Million
Q1 2024

May 13, 2024

SELL
$210.76 - $249.51 $882,873 - $1.05 Million
-4,189 Reduced 98.77%
52 $12,000
Q4 2023

Feb 09, 2024

SELL
$214.88 - $256.94 $91,753 - $109,713
-427 Reduced 9.15%
4,241 $932,000
Q3 2023

Nov 13, 2023

BUY
$211.82 - $248.24 $5,930 - $6,950
28 Added 0.6%
4,668 $1.05 Million
Q2 2023

Aug 10, 2023

BUY
$205.19 - $232.99 $7,797 - $8,853
38 Added 0.83%
4,640 $1.03 Million
Q1 2023

May 10, 2023

SELL
$212.99 - $276.17 $425 - $552
-2 Reduced 0.04%
4,602 $1.03 Million
Q4 2022

Feb 13, 2023

BUY
$205.95 - $280.43 $6,178 - $8,412
30 Added 0.66%
4,604 $1.28 Million
Q3 2022

Nov 09, 2022

BUY
$203.3 - $244.17 $31,104 - $37,358
153 Added 3.46%
4,574 $958,000
Q1 2022

May 12, 2022

BUY
$166.16 - $213.96 $224,482 - $289,059
1,351 Added 44.01%
4,421 $793,000
Q4 2021

Jan 27, 2022

BUY
$184.32 - $216.08 $206,438 - $242,009
1,120 Added 57.44%
3,070 $663,000
Q3 2021

Nov 12, 2021

BUY
$179.86 - $214.88 $8,993 - $10,744
50 Added 2.63%
1,950 $360,000
Q1 2021

May 13, 2021

SELL
$153.94 - $174.85 $8,004 - $9,092
-52 Reduced 2.66%
1,900 $317,000
Q4 2020

Feb 09, 2021

BUY
$101.87 - $151.79 $5,297 - $7,893
52 Added 2.74%
1,952 $296,000
Q3 2020

Nov 12, 2020

SELL
$99.9 - $121.13 $686,912 - $832,889
-6,876 Reduced 78.35%
1,900 $192,000
Q2 2020

Aug 05, 2020

BUY
$92.74 - $125.82 $813,886 - $1.1 Million
8,776 New
8,776 $1.06 Million
Q1 2019

May 13, 2019

SELL
$107.15 - $126.84 $11,679 - $13,825
-109 Closed
0 $0
Q3 2018

Nov 06, 2018

BUY
$113.81 - $129.46 $12,405 - $14,111
109 New
109 $14,000
Q4 2017

Jan 30, 2018

SELL
$118.58 - $151.28 $16,008 - $20,422
-135 Closed
0 $0
Q3 2017

Nov 03, 2017

BUY
$114.6 - $136.81 $15,471 - $18,469
135
135 $16,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.